Page last updated: 2024-11-04

tazarotene and Benign Neoplasms

tazarotene has been researched along with Benign Neoplasms in 1 studies

tazarotene: a topical acetylenic retinoid; a topical kerytolytic
tazarotene : The ethyl ester of tazarotenic acid. A prodrug for tazarotenic acid, it is used for the treatment of psoriasis, acne, and sun-damaged skin.

Research Excerpts

ExcerptRelevanceReference
"Tazarotene is an acetylenic retinoid which is metabolised to tazarotenic acid and which binds selectively to the retinoid receptors RARbeta and RARgamma."2.71A phase 1 study of tazarotene in adults with advanced cancer. ( Burnett, RD; Fainaru, I; Ganesan, TS; Harris, AL; Jones, PH; Nadolny, P; Rustin, GJ; Talbot, DC; Tang-Liu, D; Walker, P; Yu, Z, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jones, PH1
Burnett, RD1
Fainaru, I1
Nadolny, P1
Walker, P1
Yu, Z1
Tang-Liu, D1
Ganesan, TS1
Talbot, DC1
Harris, AL1
Rustin, GJ1

Trials

1 trial available for tazarotene and Benign Neoplasms

ArticleYear
A phase 1 study of tazarotene in adults with advanced cancer.
    British journal of cancer, 2003, Sep-01, Volume: 89, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Dose-Response Relationship, Drug; Female; Huma

2003